2 completed, 1 active not recruiting, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Craniotomy: new trials by email Literature Review of Craniotomy trials Research Report on Craniotomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study Craniotomy, Cesium-131 brachytherapy - Recurrent Brain Metastases | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 103 | 2020-12-24 | 2026-06-04 |
| Bevacizumab With or Without Surgery for Adult Glioblastomas Craniotomy - Glioblastoma, Brain Neoplasm | Phase 2 | Withdrawn | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-07-15 | 2017-07-02 | |
| HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM HSPPC-96, Temozolomide, Standard Surgical Resection - Brain and Central Nervous System Tumors | Phase 2 | Completed | University of California, San Francisco | 70 | 2009-06-29 | 2021-03-24 |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 96 | 2005-11-18 | 2021-05-13 |
Brain Neoplasms (3) · Central Nervous System Neoplasms (2) · Glioblastoma (2)
University of California, San Francisco (2) · Memorial Sloan Kettering Cancer Center (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
United States (3)
Jennifer Clarke, MD (2) · John K Park, M.D. (1) · Nelson Moss, MD (1)
P50CA097257 (1), R01CA164714 (1)